We desperately need to develop new treatments for secondary progressive MS, and I am cautiously very excited about our findings, which are a step towards developing a cell therapy for treating MS.
Following the treatment, researchers followed the patients over 12 months, observing no treatment-related deaths or serious adverse effects. Some side effects were observed, researchers said, however, they were deemed either temporary or reversible. These included minor infections and tremors. One patient suffered a steroid-induced psychosis one month after the injection, but went on to make a full recovery. At the start of the trial, most of the patients required wheelchairs and showed high levels of disability, but this did not worsen in the year after the treatment. Researchers said the findings, published in Cell Stem Cell, point to a substantial stability of the disease, without signs of progression, though the high levels of disability at the start of the trial make this difficult to confirm.
[
add
]
[
|
|
...
]